Diabetes Outcome Indicators: Blood Pressure, A1C, and LDL
This paper examines the development and application of diabetes outcome indicators used to measure the quality of diabetes care. Focusing on three core measures established by the Diabetes Quality Improvement Program (DQIP)—systolic blood pressure, hemoglobin A1C, and LDL cholesterol—the paper discusses the clinical rationale behind each threshold, the percentage of patients failing to meet established targets, and the trade-offs involved in setting stricter thresholds. The paper highlights that only an estimated 14% of diabetic patients meet all three targets simultaneously, raising important questions about the feasibility and potential harms of lowering threshold values.
- Introduction to Diabetes Outcome Indicators: Context for diabetes care quality measurement
- Core Outcome Measures and Their Thresholds: Blood pressure, A1C, and LDL thresholds explained
- Patient Achievement Rates and Target Gaps: Statistics on patients failing to meet targets
- Risks of Lowering Threshold Values: Dangers of setting stricter clinical thresholds
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Uses specific numerical thresholds (e.g., sBP <160 mmHg, A1C <9%) to ground abstract quality-of-care concepts in measurable clinical benchmarks.
- Incorporates peer-reviewed sources to support claims about patient achievement rates and the limitations of current targets.
- Balances description of existing standards with a critical observation about the potential harm of overly aggressive threshold reduction.
Key academic technique demonstrated
The paper demonstrates evidence-based argumentation by pairing statistical data (e.g., 33–49% of patients missing glycemia targets; only 14% meeting all three indicators) with a nuanced caution against simply tightening thresholds. This technique moves the analysis beyond description into a brief evaluative critique of clinical policy.
Structure breakdown
The paper opens with contextual framing around diabetes prevalence and its burden on healthcare systems, then introduces the three DQIP outcome indicators. It progresses through each measure's threshold and rationale, reports patient achievement rates with supporting statistics, and concludes by questioning whether lowering thresholds would improve or worsen patient outcomes. The argument flows logically from definition to measurement to critical evaluation.
Introduction to Diabetes Outcome Indicators
Diabetes outcome indicators have been developed and utilized to measure progress on managing this condition. Their development is attributable to the increased prevalence of diabetes worldwide, which places substantial burdens on healthcare systems. Consequently, diabetes management has become a major concern in the public health sector. According to O'Connor et al. (2011), diabetes outcome indicators relating to care include control of blood pressure, hemoglobin A1C, and LDL cholesterol. These outcome indicators were among the initial Diabetes Quality Improvement Program (DQIP) measures and have been included in subsequent sets of diabetes quality measurements.
Core Outcome Measures and Their Thresholds
These outcome indicators have been developed and are utilized because they are risk factors that predict clinical outcomes and relate to the challenges and complexities associated with diabetes. Systolic blood pressure levels (sBP) are set at <160 mmHg, which is the dichotomous threshold goal for all diabetic patients. Diabetic patients whose blood pressure levels exceed this threshold require additional pharmacologic or lifestyle intervention. The achievement of this outcome indicator is relatively high because the threshold is set at a permissive level. However, when the threshold is lowered, many diabetic patients are unable to meet it, resulting in the need for additional treatment.
With regard to glycated hemoglobin A1C control, many patients are unable to meet the established threshold of A1C <9%. This measure is a critical indicator of long-term blood glucose management and is central to assessing the effectiveness of diabetes care at both the individual and population level.
Patient Achievement Rates and Target Gaps
Even though there has been a national decline in poor glycemic control, between 33% and 49% of patients still fail to meet the established targets for glycemia (Mitri & Gabbay, 2016). Additionally, the same percentage of patients fail to meet targets for low-density lipoprotein (LDL) cholesterol control. It is estimated that only 14% of diabetics meet the established targets for all three outcome indicators, owing to the high thresholds set across each of the measures.
References
Mitri, J., & Gabbay, R. A. (2016, March). Measuring the quality of diabetes care. American Journal of Managed Care. Retrieved October 2, 2018, from https://www.ajmc.com/journals/evidence-based-diabetes-management/2016/march-2016/measuring-the-quality-of-diabetes-care
O'Connor et al. (2011, July). Diabetes performance measures: Current status and future directions. Diabetes Care, 34(7), 1651–1659. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120200/
Create your account
Always verify citation format against your institution’s current style guide requirements.